ADVFN US – Market Content Editor

  • Liquidia Shares Climb After First Commercial Shipment of YUTREPIA

    Liquidia Shares Climb After First Commercial Shipment of YUTREPIA

    Liquidia Technologies Inc (NASDAQ:LQDA) saw its shares rise nearly 10% following news that it will begin its initial commercial shipments of YUTREPIA™ (treprostinil) inhalation powder. This milestone follows FDA approval granted on May 23, 2025, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension linked to interstitial lung disease (PH-ILD). The product will…

  • ATAI Life Sciences Shares Jump Following Merger Announcement with Beckley Psytech

    ATAI Life Sciences Shares Jump Following Merger Announcement with Beckley Psytech

    ATAI Life Sciences BV (NASDAQ:ATAI) experienced an 18.6% surge in its stock price after announcing a planned merger with Beckley Psytech, a strategic move aimed at forming a global leader in psychedelic-based mental health treatments. The all-stock deal, expected to close in the latter half of 2025, will result in a combined company named atai…

  • Cactus to Acquire Majority Stake in Baker Hughes’ Surface Pressure Control Unit

    Cactus to Acquire Majority Stake in Baker Hughes’ Surface Pressure Control Unit

    Cactus Companies (NYSE:WHD), a subsidiary of Cactus, announced plans to purchase a 65% controlling interest in Baker Hughes’ (NASDAQ:BKR) Surface Pressure Control (SPC) business. The transaction, valued at $344.5 million, will result in Baker Hughes retaining a 35% ownership stake in the SPC unit after closing. The overall enterprise value of the deal is approximately…

  • Applied Digital Stock Climbs 13% on Major AI Data Center Lease Deal with CoreWeave

    Applied Digital Stock Climbs 13% on Major AI Data Center Lease Deal with CoreWeave

    Shares of Applied Digital Corporation (NASDAQ:APLD) surged 13% after the company announced a landmark lease agreement involving its forthcoming AI-focused data center in North Dakota. Applied Digital revealed it has signed two long-term leases, each spanning around 15 years, with CoreWeave – a prominent provider in artificial intelligence (AI) and high-performance computing (HPC) – to…

  • Wells Fargo Highlights Growth of Companies Holding Bitcoin on Their Balance Sheets

    Wells Fargo Highlights Growth of Companies Holding Bitcoin on Their Balance Sheets

    Wells Fargo has identified a growing trend of companies adopting Bitcoin (COIN:BTCUSD) in a more institutional manner, coining the term “Bitcoin Treasury Corps” to describe firms that leverage capital markets to accumulate significant Bitcoin reserves. In a recent report, Wells Fargo stated, “Bitcoin is entering an institutional phase,” spotlighting an increasing number of businesses that…

  • JetBlue CEO Affirms Partnership with United Airlines Is Not a Merger Step

    JetBlue CEO Affirms Partnership with United Airlines Is Not a Merger Step

    JetBlue Airways (NASDAQ:JBLU) CEO Joanna Geraghty emphasized on Monday that the airline’s recent alliance with United Airlines (NASDAQ:UAL) should not be seen as a prelude to a merger. The two carriers announced the partnership last week, aiming to enhance travel options for their customers. Under the collaboration, passengers can now book flights through either JetBlue’s…

  • U.S. Stocks Open the New Month Mixed Amid Trade Worries

    U.S. Stocks Open the New Month Mixed Amid Trade Worries

    U.S. stock indices opened the week on a mixed note as renewed tensions between China and the U.S. reignited concerns of a potential trade war between the two largest global economies. At 09:32 ET (13:32 GMT), the Dow Jones Industrial Average fell 170 points (0.4%), the S&P 500 dropped 11 points (0.2%), while the Nasdaq…

  • Vera Therapeutics Shares Jump 80% on Strong Phase 3 Trial Results for Atacicept

    Vera Therapeutics Shares Jump 80% on Strong Phase 3 Trial Results for Atacicept

    Vera Therapeutics, Inc. (NASDAQ:VERA) saw its stock soar by 80% following the announcement of encouraging data from its ORIGIN Phase 3 trial evaluating atacicept, a potential treatment for immunoglobulin A nephropathy (IgAN). The trial demonstrated that atacicept significantly reduced proteinuria – a key marker of kidney damage – by 46% from baseline and 42% versus…

  • Meta Aims to Automate Ad Creation with AI by 2026

    Meta Aims to Automate Ad Creation with AI by 2026

    Meta Platforms (NASDAQ:META), the parent company of Facebook and Instagram, is reportedly advancing plans to enable fully automated ad creation and delivery through artificial intelligence by the end of 2026, according to a Wall Street Journal report citing company sources. The tech giant, whose social apps serve a combined 3.43 billion unique users globally, is…

  • Campbell Soup Tops Q3 Expectations, Maintains Full-Year Outlook

    Campbell Soup Tops Q3 Expectations, Maintains Full-Year Outlook

    Campbell Soup Company (NYSE:CPB) exceeded Wall Street’s expectations in its fiscal third-quarter earnings report, buoyed by the integration of Sovos Brands and a rebound in at-home food consumption across income levels. The company reported adjusted earnings per share of $0.73, outpacing the consensus forecast of $0.65. Revenue came in at $2.48 billion, a 4% increase…